Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization

Texto completo
Autor(es):
Rocha, Thais [1] ; Crespo, Raiane P. [1] ; Yance, Viviane V. R. [1] ; Hayashida, Sylvia A. [2] ; Baracat, Edmund C. [2] ; Carvalho, Filomena [3] ; Domenice, Sorahia [1] ; Mendonca, Berenice B. [1] ; Gomes, Larissa G. [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Endocrinol Desenvolvimento, Disciplina Endocrinol & Metabol, Lab Hormonios & G, BR-0540100 Sao Paulo - Brazil
[2] Univ Sao Paulo, Hosp Clin, Dept Obstetricia & Ginecol, Fac Med, Disciplina Ginecol, BR-0540100 Sao Paulo - Brazil
[3] Univ Sao Paulo, Fac Med, Disciplina Patol, BR-01246903 Sao Paulo - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF THE ENDOCRINE SOCIETY; v. 3, n. 5, p. 1087-1096, MAY 2019.
Citações Web of Science: 0
Resumo

Context: Data on prevalence of metabolic risk factors in hyperandrogenic postmenopausal women are limited. Also, the correlation between metabolic disorders and androgen excess in this scenario is poorly understood. Objectives: We aimed to assess the prevalence of obesity, hypertension, type 2 diabetes (T2D), and dyslipidemia (DLP) in postmenopausal women with hyperandrogenism of ovarian origin before and after surgical normalization of testosterone (T) levels, as well as the impact of androgen normalization on body mass index (BMI), glucose, and lipid metabolism. Design: Retrospective study. Setting: Tertiary health center. Participants: Twenty-four Brazilian women with postmenopausal hyperandrogenism who underwent bilateral oophorectomy between 2004 and 2014 and had histologically confirmed virilizing ovarian tumor (VOT) or ovarian hyperthecosis (OH) and T-level normalization after surgery were selected. Main Outcome Measures: FSH, LH, total and calculated free T, BMI, fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride (TG) serum levels were accessed before (n = 24) and 24 months after (n 5 19) bilateral oophorectomy. Results: At baseline, the overall prevalence rates of obesity, T2D, DLP, and hypertension were 58.3%, 83.3%, 66.7%, and 87.5%, respectively. No significant difference in prevalence was found between patients with OH and VOTs. At follow-up, FSH, LH, and total and free T levels had returned to menopausal physiologic levels, but mean BMI and mean FPG, HbA1c, LDL-C, HDL-C, and TG levels did not differ from baseline. Conclusions: Postmenopausal hyperandrogenism is associated with adverse metabolic risk. Longterm normalization of testosterone levels did not improve BMI, glucose, or lipid metabolism. Copyright (C) 2019 Endocrine Society (AU)

Processo FAPESP: 15/17350-0 - Identificação de Genes Associados à Etiologia da Síndrome dos Ovários Policísticos por Sequenciamento em Larga Escala
Beneficiário:Larissa Garcia Gomes
Modalidade de apoio: Auxílio à Pesquisa - Regular